Velocity Clinical Research, Inc.’s Post

🙌 Congratulations, Argá Medtech SA, on closing an oversubscribed EUR 54 M Series B financing, a testament to the outstanding team and excellent technical data! Existing investors Earlybird Health and Advent Life Sciences led the round alongside new investors Gilde Healthcare and an undisclosed strategic. 🫀 Argá Medtech is developing the Coherent Sine-Burst Electroporation™ (CSE™), a next-generation non-thermal cardiac ablation system for treating cardiac arrhythmias, including atrial fibrillation (AF). AF is the most prevalent heart arrhythmia globally, affecting approximately 38 million patients, who are 5x more susceptible to stroke. This financing enables Argá Medtech to advance its innovative CSE™ Pulsed Field Ablation (PFA) system for AF treatment through an IDE study in the US and a CE Mark study in the EU. Additionally, the Company will further expand its US offices in San Diego, CA, in preparation for US clinical activities. 👀 For more information, refer to the press release: https://bit.ly/3IcR1ar With: David Neale, Randy Werneth, John Yianni, Florent Gros, Rabab Nasrallah, PhD, Shahzad Malik, and more #EBVCgang #Healthcare #SeriesB #Europe #US

SCOPE starts this weekend, and Segmed is thrilled to be a sponsor. Are you planning to attend this conference? Don't miss out on our latest blog article highlighting the Top Reasons You Can't Afford to Miss Segmed at the summit. Check it out https://hubs.li/Q02kbM3r0 #SCOPESummit #Segmed #ClinicalTrials #ClinicalResearch #ClinicalOperations #RWiD #ImagingDatasets

Great to see Steph Eaneff showcasing the process we use to learn and develop our products in this poster presented at @DTx West. By iterating on clinical studies, testing new concepts, and generating new hypotheses to validate in future studies, we’re creating the dynamic cycle that keeps Woebot well ahead. #dtx #digitaltherapeutics #digitalhealth #digitalhealthinnovation

ASRS – American Society of Retina Specialists conference is shaping up to be an amazing event. If you are planning to attend, swing by Table 15 to learn more about how Viewgol drives improved financial performance. #viewgolat #ASRS #Retina #BusinessofRetina #rcmservices #rcmheros #analytics

Register for this webinar to learn how configurable solutions are transforming study launches by reducing coding errors, enhancing consistency across studies and enabling the acquisition of more reliable data. This not only streamlines the process but also makes it more cost-effective compared to traditional customized solutions that require complex and lengthy implementations.

🏁 𝗙𝗿𝗼𝗺 𝗦𝗺𝗼𝗼𝘁𝗵 𝗧𝗿𝗮𝗰𝗸𝘀 𝘁𝗼 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗥𝗼𝗮𝗱𝘀: 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝘄𝗶𝘁𝗵 𝗦𝗽𝗲𝗲𝗱 𝗮𝗻𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 🚗🌍 🚗 𝘗𝘩𝘢𝘴𝘦 3 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘛𝘳𝘪𝘢𝘭𝘴: 𝘛𝘩𝘦 𝘗𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘙𝘢𝘤𝘦𝘵𝘳𝘢𝘤𝘬 Imagine taking a supercar onto a flawless racetrack. The sun is shining, the road is perfect, and there are no surprises—just pure, controlled speed. This is Phase 3 clinical trials: testing a drug in an ideal, controlled setting to see its true potential. 🏙️ 𝘗𝘩𝘢𝘴𝘦 4 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘛𝘳𝘪𝘢𝘭𝘴: 𝘛𝘩𝘦 𝘜𝘳𝘣𝘢𝘯 𝘑𝘶𝘯𝘨𝘭𝘦 Now, unleash that supercar into the bustling city streets. There’s traffic, potholes, and unpredictable chaos everywhere. This is Phase 4 clinical trials: testing a drug in the real world, with all its messy, unpredictable conditions. ⚖️ Summary Phase 3 clinical trials are the supercar's showcase on a perfect track, proving its worth. Phase 4 clinical trials are the real-world test, navigating everyday chaos to ensure it performs under any condition.

🌟 Introducing OptiVision®: Better Images Without Additional Radiation Exposure 🌟 Proper visualization is crucial for effective ESWL treatments. Dornier MedTech Delta® III’s OptiVision® uses intelligent algorithms to enhance images, overcoming challenges like obesity and bowel gases. 🔍 Better diagnosis 🔍 Better treatment 🔍 Better patient follow-up All this at no additional radiation risk. Upgrade your imaging capabilities with Dornier Delta® III! #UrologyInnovation #HealthcareTech #BetterImaging

Yesterday, we hosted an insightful webinar with Prof. Duncan McLaren! Prof. McLaren discussed the PACE B study, highlighting potential links between acute GU toxicity and late toxicity. Some data also suggest that the use of fiducial markers and a regular LINAC also might be associated with higher toxicity. A key question raised: What are the benefits of using a catheter in prostate SBRT? This will be investigated in the upcoming PRECISION trial, a phase 2 study launching soon in the EU and US. The team in Scotland is just weeks away from enrolling their first patient, with 100 patients being the initial goal for all starting centers. The conversation also revolved around how the urethra is becoming the “new kid on the block” in prostate SBRT. More professionals are recognizing the patient benefits of focusing on the urethra, which naturally integrates into the workflow when using a catheter that enables urethra outlining during SBRT. Interested in learning more? We’re considering a follow-up session later this fall. By then, several centers, including Edinburgh, will have started the three-fraction protocol. Thanks to Prof. McLaren and everyone who joined! #ProstateCancer #SBRT #Radiotheraphy #Raypilot

📍 Are you heading to #ECTRIMS2024? Emma Gray from the MS Society is looking to speak to potential industry collaborators for the OCTOPUS clinical trial in progressive #MultipleScleroisis. Get in touch with Emma to find out more 👇 #MSResearch #Pharmaceuticals